Amarin Corp Plcuk (AMRN) Total Liabilities (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Total Liabilities of $196.4 million for Q1 2026, up 7.89% YoY from $182.0 million in Q1 2025, and down 7.16% sequentially from $211.5 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Total Liabilities (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Total Liabilities across 17 years of filings, most recently posting $196.4 million for Q1 2026.

  • In Q1 2026, Total Liabilities rose 7.89% year-over-year to $196.4 million; the TTM figure through Mar 2026 stood at $196.4 million (up 7.89% YoY), while the FY2025 annual figure was $211.5 million, up 6.19% from the prior year.
  • Total Liabilities slipped to $196.4 million in Q1 2026, from $211.5 million in the prior quarter.
  • Over the last five years, Total Liabilities for AMRN reached as high as $393.2 million in Q2 2022 and fell as low as $182.0 million in Q1 2025.
  • The 5-year median for Total Liabilities is $248.0 million (2024), against an average of $257.4 million.
  • Annual changes were most pronounced in 2024 — Total Liabilities declined 28.76% — and 2026, when it grew 7.89%.
  • A 5-year view of Total Liabilities shows it stood at $290.8 million in 2022, then decreased by 3.87% to $279.6 million in 2023, then decreased by 28.76% to $199.2 million in 2024, then grew by 6.19% to $211.5 million in 2025, then declined by 7.16% to $196.4 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $196.4 million, $211.5 million, and $200.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 85.38 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 119.71 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 143.12 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -66.63 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 82.81 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 83.31 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 32.76 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 117.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 196.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 196.35 Mn
Dec 31, 2025 211.49 Mn
Sep 30, 2025 200.92 Mn
Jun 30, 2025 205.20 Mn
Mar 31, 2025 181.99 Mn
Dec 31, 2024 199.17 Mn
Sep 30, 2024 219.24 Mn
Jun 30, 2024 247.98 Mn
Mar 31, 2024 244.08 Mn
Dec 31, 2023 279.59 Mn
Sep 30, 2023 285.88 Mn
Jun 30, 2023 290.89 Mn
Mar 31, 2023 275.40 Mn
Dec 31, 2022 290.85 Mn
Sep 30, 2022 320.48 Mn
Jun 30, 2022 393.19 Mn
Mar 31, 2022 332.60 Mn
Dec 31, 2021 400.97 Mn
Sep 30, 2021 393.31 Mn
Jun 30, 2021 399.67 Mn